FIELD: pharmaceuticals.
SUBSTANCE: invention relates to furan-2-ylmethyl-2-(2-(diphenylmethylene)hydrazinyl)-5,5-dimethyl-4-oxohex-2-enoate by the formula (1).
EFFECT: production of a new compound with pronounced analgesic and anti-inflammatory activity, as well as low toxicity, applicable in medicine.
1 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| N-(1-H-BENZO[d]IMIDAZOLE-2-yl)-2-(2-(DIPHENYLMETHYLENE)HYDRAZINYL)-5,5-DIMETHYL-4-OXOHEX-2-ENEAMIDE EXHIBITING ANALGESIC ACTIVITY | 2021 |
|
RU2786673C1 |
| USE OF SUBSTITUTED ESTERS OF (Z)-2-(2-(DIPHENYLMETHYLENE)HYDRAZINYL)-5,5-DIMETHYL-4-OXOHEX-2-ENOIC ACID AS AN ANTIBACTERIAL AND ANTIFUNGAL AGENT | 2021 |
|
RU2768761C1 |
| SUBSTITUTED HYDRAZIDES OF 2-DIARYLMETHYLENE HYDRAZONE-5,5-DIMETHYL-4-OXOHEXANOIC ACIDS EXHIBITING ANTI-INFLAMMATORY ACTIVITY | 2021 |
|
RU2783158C2 |
| N-(4'-METHYLBENZOYL)-3,5-DICHLOROANTHRANILIC ACID BUTYLAMIDE EXHIBITING ANTI-INFLAMMATORY AND ANALGETIC ACTIVITY | 2020 |
|
RU2753655C1 |
| TRIS {[1-(6-METHYLBENZO[D]THIAZOL-2-YL)AMINO-1,4-DIOXO-4-(P-TOLYL) BUT-2-EN-2-YL]OXY} IRON HAVING ANTI-INFLAMMATORY ACTION | 2018 |
|
RU2717242C2 |
| 1-HEXADECYL-4,6-DIMETHYL-2-OXONICOTINAMIDE EXHIBITING ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY | 2008 |
|
RU2396258C2 |
| 2-{[2-(ADAMANTAN-1-YL)-2-OXOETHYLIDENEHYDRAZINYL-4-(Β-NAPHTHALYL)-4-OXOBUT-2-ENOYL]THIO} SODIUM ETHANOATE WITH WOUND HEALING AND ANTI-INFLAMMATORY ACTIVITY | 2023 |
|
RU2808431C1 |
| ETHYL 4-(5-BENZOYL-6-(4-(DIETHYLAMINO)PHENYL)-4-HYDROXY-2-THIOXOHEXAHYDROPYRIMIDIN-4-CARBOXAMINO)BENZOATE, EXHIBITING ANALGESIC AND ANTI-INFLAMMATORY ACTION | 2019 |
|
RU2717246C1 |
| N-(2-THIAZOLYL)AMIDE OF 2-(2-OXO-3-INDOLINYLIDENE)HYDRAZINO-4-OXO-4-PHENYL-2-BUTENOIC ACID HAVING ANTIBACTERIAL AND ANALGESIC ACTIVITY | 2008 |
|
RU2401837C2 |
| 4-(4-METHYLPHENYL)-4-OXO-2-[3-(ETHOXYCARBONYL-4,5-R,R-THIOPHEN-2-YLAMINO]BUT-2-ENOIC ACID, HAVING ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY | 2008 |
|
RU2389724C1 |
